The pharmaceutical strategy for Europe, to be published by the European Commission (EC) before the end of the year, should centre on transparency and robust evidence, support public health priorities and ensure evidence-based independent policy elaboration, assessments and surveillance of medicines and full access to clinical data. Learn more...